Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.

about

Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499.General Biomarker Recommendations for Lymphoma.Current trials for frontline therapy of mantle cell lymphoma.

P2860

Q42324646-20CDBC07-8A9E-468F-B272-7E3C61EB9C54 Q47593563-92F32DBA-EB5A-46AA-9075-F75198B8C7A9 Q49279565-BECF1D37-9986-4BC3-91F6-F6637B801E41

P2860

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.

Item

http://www.wikidata.org/entity/Q39045701

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.

@en

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.

@nl

type

Item

label

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.

@en

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.

@nl

prefLabel

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.

@en

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.

@nl

P1476

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma

@en

P2093

Andre H Goy

http://www.w3.org/2001/XMLSchema#string

Brad S Kahl

http://www.w3.org/2001/XMLSchema#string

Brian G Till

http://www.w3.org/2001/XMLSchema#string

John P Leonard

http://www.w3.org/2001/XMLSchema#string

Jonathan W Friedberg

http://www.w3.org/2001/XMLSchema#string

Lawrence Baizer

http://www.w3.org/2001/XMLSchema#string

Martin P Dreyling

http://www.w3.org/2001/XMLSchema#string

Michael LeBlanc

http://www.w3.org/2001/XMLSchema#string

Mitchell R Smith

http://www.w3.org/2001/XMLSchema#string

Peter Martin

http://www.w3.org/2001/XMLSchema#string

P2860

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma.

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Postibrutinib outcomes in patients with mantle cell lymphoma.

Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma

Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.

P31

scholarly article

P356

10.1093/JNCI/DJW263

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Ajay K Gopal

P577

2016-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28040733

http://www.w3.org/2001/XMLSchema#string

P932

6059122

http://www.w3.org/2001/XMLSchema#string

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.

about

P2860

P2860

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932